1. Therapeutic Potential of AMPA Receptor Ligands in Neurological Disorders
2. For an excellent review on the compounds which inhibit AMPA receptor function see: Chimirri, A.; Gitto, R.; Zappala, M. Exp. Opin. Ther. Pat. 1999, 9, 557.
3. Synthesis and Anticonvulsant Activity of Some New 3,6-Disubstituted-2-[2-oxo-2-(4-pyridyl)ethyl]-4(3H)-pyrimidinones
4. Menniti, F. S.; Collins, M.; Ducat, M. F.; Kelly, K. A.; Pagnozzi, M. J.; Richter, K. E. G. Abstracts of Papers; 28th Annual Meeting of the Society for Neuroscience, Los Angeles, CA, 1998; pp 99, Abstract 44.12. Lazzaro, J. T.; Ganong, A. H. Abstracts of Papers; 28th Annual Meeting of the Society for Neuroscience, Los Angeles, CA, 1998; pp 99, Abstract 44,13. Menniti, F. S.; Chenard, B. L.; Collins, M. B.; Ducat, M. F.; Elliott, M. L.; Ewing, F. E.; Huang, J.-I.; Kelly, K. A.; Lazzaro, J. T.; Pagnozzi, M. J.; Weeks, J. L.; Welch, W. M.; White W. F. Mol. Pharmacol., submitted for publication.